Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit.
Preclinical Research and Development, GTx, Inc., 3 North Dunlap Street, Memphis, Tennessee 38163, USA.
Michael L
ML
Mohler
Casey E
CE
Bohl
Amanda
A
Jones
Christopher C
CC
Coss
Ramesh
R
Narayanan
Yali
Y
He
Dong Jin
DJ
Hwang
James T
JT
Dalton
Duane D
DD
Miller
D000577:Amides / Q000737:chemistry / Q000494:pharmacology*; D045930:Anabolic Agents / Q000737:chemistry / Q000494:pharmacology*; D059002:Androgen Receptor Antagonists; D000728:Androgens / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D008958:Models, Molecular; D015363:Quinolones / Q000737:chemistry / Q000494:pharmacology*; D011944:Receptors, Androgen / Q000378:metabolism*; D013329:Structure-Activity Relationship
D000577:Amides; D045930:Anabolic Agents; D059002:Androgen Receptor Antagonists; D000728:Androgens; D015363:Quinolones; D011944:Receptors, Androgen; C034666:propionamide